Global Anti Obesity Drugs Market Professional Survey Report 2019
SKU ID :QYR-14956388 | Published Date: 04-Dec-2019 | No. of pages: 119Description
TOC
Table of Contents
Executive Summary
1 Industry Overview of Anti Obesity Drugs
1.1 Definition of Anti Obesity Drugs
1.2 Anti Obesity Drugs Segment by Type
1.2.1 Global Anti Obesity Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral Medicine
1.2.3 Diet Patch
1.2.4 Diet Tea
1.3 Anti Obesity Drugs Segment by Applications
1.3.1 Global Anti Obesity Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Men
1.3.3 Women
1.4 Global Anti Obesity Drugs Overall Market
1.4.1 Global Anti Obesity Drugs Revenue (2014-2025)
1.4.2 Global Anti Obesity Drugs Production (2014-2025)
1.4.3 North America Anti Obesity Drugs Status and Prospect (2014-2025)
1.4.4 Europe Anti Obesity Drugs Status and Prospect (2014-2025)
1.4.5 China Anti Obesity Drugs Status and Prospect (2014-2025)
1.4.6 Japan Anti Obesity Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Anti Obesity Drugs Status and Prospect (2014-2025)
1.4.8 India Anti Obesity Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Anti Obesity Drugs
2.3 Manufacturing Process Analysis of Anti Obesity Drugs
2.4 Industry Chain Structure of Anti Obesity Drugs
3 Development and Manufacturing Plants Analysis of Anti Obesity Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Anti Obesity Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Anti Obesity Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Anti Obesity Drugs Production and Capacity Analysis
4.2 Anti Obesity Drugs Revenue Analysis
4.3 Anti Obesity Drugs Price Analysis
4.4 Market Concentration Degree
5 Anti Obesity Drugs Regional Market Analysis
5.1 Anti Obesity Drugs Production by Regions
5.1.1 Global Anti Obesity Drugs Production by Regions
5.1.2 Global Anti Obesity Drugs Revenue by Regions
5.2 Anti Obesity Drugs Consumption by Regions
5.3 North America Anti Obesity Drugs Market Analysis
5.3.1 North America Anti Obesity Drugs Production
5.3.2 North America Anti Obesity Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Anti Obesity Drugs Import and Export
5.4 Europe Anti Obesity Drugs Market Analysis
5.4.1 Europe Anti Obesity Drugs Production
5.4.2 Europe Anti Obesity Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Anti Obesity Drugs Import and Export
5.5 China Anti Obesity Drugs Market Analysis
5.5.1 China Anti Obesity Drugs Production
5.5.2 China Anti Obesity Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Anti Obesity Drugs Import and Export
5.6 Japan Anti Obesity Drugs Market Analysis
5.6.1 Japan Anti Obesity Drugs Production
5.6.2 Japan Anti Obesity Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Anti Obesity Drugs Import and Export
5.7 Southeast Asia Anti Obesity Drugs Market Analysis
5.7.1 Southeast Asia Anti Obesity Drugs Production
5.7.2 Southeast Asia Anti Obesity Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Anti Obesity Drugs Import and Export
5.8 India Anti Obesity Drugs Market Analysis
5.8.1 India Anti Obesity Drugs Production
5.8.2 India Anti Obesity Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Anti Obesity Drugs Import and Export
6 Anti Obesity Drugs Segment Market Analysis (by Type)
6.1 Global Anti Obesity Drugs Production by Type
6.2 Global Anti Obesity Drugs Revenue by Type
6.3 Anti Obesity Drugs Price by Type
7 Anti Obesity Drugs Segment Market Analysis (by Application)
7.1 Global Anti Obesity Drugs Consumption by Application
7.2 Global Anti Obesity Drugs Consumption Market Share by Application (2014-2019)
8 Anti Obesity Drugs Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Anti Obesity Drugs Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Merck
8.2.1 Merck Anti Obesity Drugs Production Sites and Area Served
8.2.2 Merck Product Introduction, Application and Specification
8.2.3 Merck Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Roche
8.3.1 Roche Anti Obesity Drugs Production Sites and Area Served
8.3.2 Roche Product Introduction, Application and Specification
8.3.3 Roche Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Anti Obesity Drugs Production Sites and Area Served
8.4.2 GlaxoSmithKline Product Introduction, Application and Specification
8.4.3 GlaxoSmithKline Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 AstraZeneca
8.5.1 AstraZeneca Anti Obesity Drugs Production Sites and Area Served
8.5.2 AstraZeneca Product Introduction, Application and Specification
8.5.3 AstraZeneca Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Boehringer Ingelheim
8.6.1 Boehringer Ingelheim Anti Obesity Drugs Production Sites and Area Served
8.6.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.6.3 Boehringer Ingelheim Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Novo Nordisk
8.7.1 Novo Nordisk Anti Obesity Drugs Production Sites and Area Served
8.7.2 Novo Nordisk Product Introduction, Application and Specification
8.7.3 Novo Nordisk Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Eisai
8.8.1 Eisai Anti Obesity Drugs Production Sites and Area Served
8.8.2 Eisai Product Introduction, Application and Specification
8.8.3 Eisai Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Norgine
8.9.1 Norgine Anti Obesity Drugs Production Sites and Area Served
8.9.2 Norgine Product Introduction, Application and Specification
8.9.3 Norgine Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Arena Pharmaceuticals
8.10.1 Arena Pharmaceuticals Anti Obesity Drugs Production Sites and Area Served
8.10.2 Arena Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Arena Pharmaceuticals Anti Obesity Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Orexigen Therapeutics
8.12 Vivus
8.13 Alizyme
8.14 Rhythm Pharmaceuticals
8.15 Shionogi
8.16 Zafgan
9 Development Trend of Analysis of Anti Obesity Drugs Market
9.1 Global Anti Obesity Drugs Market Trend Analysis
9.1.1 Global Anti Obesity Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Anti Obesity Drugs Regional Market Trend
9.2.1 North America Anti Obesity Drugs Forecast 2019-2025
9.2.2 Europe Anti Obesity Drugs Forecast 2019-2025
9.2.3 China Anti Obesity Drugs Forecast 2019-2025
9.2.4 Japan Anti Obesity Drugs Forecast 2019-2025
9.2.5 Southeast Asia Anti Obesity Drugs Forecast 2019-2025
9.2.6 India Anti Obesity Drugs Forecast 2019-2025
9.3 Anti Obesity Drugs Market Trend (Product Type)
9.4 Anti Obesity Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Anti Obesity Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Tables & Figures
List of Tables and Figures
Figure Picture of Anti Obesity Drugs
Table Global Anti Obesity Drugs Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Anti Obesity Drugs Production Market Share by Types in 2018
Figure Oral Medicine Product Picture
Figure Diet Patch Product Picture
Figure Diet Tea Product Picture
Table Global Anti Obesity Drugs Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Anti Obesity Drugs Consumption Market Share by Applications in 2018
Figure Men
Figure Women
Figure Global Anti Obesity Drugs Revenue (Million USD) (2014-2025)
Figure Global Anti Obesity Drugs Production (K MT) (2014-2025)
Figure North America Anti Obesity Drugs Market Size (Million USD) (2014-2025)
Figure Europe Anti Obesity Drugs Market Size (Million USD) (2014-2025)
Figure China Anti Obesity Drugs Market Size (Million USD) (2014-2025)
Figure Japan Anti Obesity Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Anti Obesity Drugs Market Size (Million USD) (2014-2025)
Figure India Anti Obesity Drugs Market Size (Million USD) (2014-2025)
Table Anti Obesity Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Anti Obesity Drugs in 2018
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Industry Chain Structure of Anti Obesity Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Anti Obesity Drugs Manufacturing Plants Distribution
Table Anti Obesity Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Anti Obesity Drugs Capacity (K MT) of Major Manufacturers (2014-2019)
Table Anti Obesity Drugs Production (K MT) of Major Manufacturers (2014-2019)
Table Anti Obesity Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Anti Obesity Drugs Production Share by Manufacturers in 2018
Table Anti Obesity Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Anti Obesity Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Anti Obesity Drugs Revenue Share by Manufacturers in 2018
Table Anti Obesity Drugs Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Anti Obesity Drugs Production by Regions 2014-2019 (K MT)
Table Global Anti Obesity Drugs Production Market Share by Regions 2014-2019
Figure Global Anti Obesity Drugs Production Market Share by Regions in 2018
Table Global Anti Obesity Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Anti Obesity Drugs Revenue Market Share by Regions 2014-2019
Figure Global Anti Obesity Drugs Revenue Market Share by Regions in 2018
Table Global Anti Obesity Drugs Consumption by Regions 2014-2019 (K MT)
Table Global Anti Obesity Drugs Consumption Market Share by Regions 2014-2019
Figure North America Anti Obesity Drugs Production Growth Rate 2014-2019 (K MT)
Figure North America Anti Obesity Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Anti Obesity Drugs Production, Consumption Import and Export (K MT)
Figure Europe Anti Obesity Drugs Production Growth Rate 2014-2019 (K MT)
Figure Europe Anti Obesity Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Anti Obesity Drugs Production, Consumption Import and Export (K MT)
Figure China Anti Obesity Drugs Production Growth Rate 2014-2019 (K MT)
Figure China Anti Obesity Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Anti Obesity Drugs Production, Consumption Import and Export (K MT)
Figure Japan Anti Obesity Drugs Production Growth Rate 2014-2019 (K MT)
Figure Japan Anti Obesity Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Anti Obesity Drugs Production, Consumption Import and Export (K MT)
Figure Southeast Asia Anti Obesity Drugs Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Anti Obesity Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Anti Obesity Drugs Production, Consumption Import and Export (K MT)
Figure India Anti Obesity Drugs Production Growth Rate 2014-2019 (K MT)
Figure India Anti Obesity Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Anti Obesity Drugs Production, Consumption Import and Export (K MT)
Figure Global Consumption Anti Obesity Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Anti Obesity Drugs Market Share by Application (2014-2019)
Table Pfizer Anti Obesity Drugs Production Sites and Area Served
Table Pfizer Anti Obesity Drugs Product Introduction, Application and Specification
Table Pfizer Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Pfizer Anti Obesity Drugs Production Market Share (2014-2019)
Figure Pfizer Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Pfizer Anti Obesity Drugs Main Business and Markets Served
Table Merck Anti Obesity Drugs Production Sites and Area Served
Table Merck Anti Obesity Drugs Product Introduction, Application and Specification
Table Merck Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Merck Anti Obesity Drugs Production Market Share (2014-2019)
Figure Merck Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Merck Anti Obesity Drugs Main Business and Markets Served
Table Roche Anti Obesity Drugs Production Sites and Area Served
Table Roche Anti Obesity Drugs Product Introduction, Application and Specification
Table Roche Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Roche Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Roche Anti Obesity Drugs Production Market Share (2014-2019)
Figure Roche Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Roche Anti Obesity Drugs Main Business and Markets Served
Table GlaxoSmithKline Anti Obesity Drugs Production Sites and Area Served
Table GlaxoSmithKline Anti Obesity Drugs Product Introduction, Application and Specification
Table GlaxoSmithKline Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Anti Obesity Drugs Production Growth Rate (2014-2019)
Table GlaxoSmithKline Anti Obesity Drugs Production Market Share (2014-2019)
Figure GlaxoSmithKline Anti Obesity Drugs Revenue Market Share (2014-2019)
Table GlaxoSmithKline Anti Obesity Drugs Main Business and Markets Served
Table AstraZeneca Anti Obesity Drugs Production Sites and Area Served
Table AstraZeneca Anti Obesity Drugs Product Introduction, Application and Specification
Table AstraZeneca Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table AstraZeneca Anti Obesity Drugs Production Growth Rate (2014-2019)
Table AstraZeneca Anti Obesity Drugs Production Market Share (2014-2019)
Figure AstraZeneca Anti Obesity Drugs Revenue Market Share (2014-2019)
Table AstraZeneca Anti Obesity Drugs Main Business and Markets Served
Table Boehringer Ingelheim Anti Obesity Drugs Production Sites and Area Served
Table Boehringer Ingelheim Anti Obesity Drugs Product Introduction, Application and Specification
Table Boehringer Ingelheim Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Anti Obesity Drugs Production Market Share (2014-2019)
Figure Boehringer Ingelheim Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Anti Obesity Drugs Main Business and Markets Served
Table Novo Nordisk Anti Obesity Drugs Production Sites and Area Served
Table Novo Nordisk Anti Obesity Drugs Product Introduction, Application and Specification
Table Novo Nordisk Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novo Nordisk Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Novo Nordisk Anti Obesity Drugs Production Market Share (2014-2019)
Figure Novo Nordisk Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Novo Nordisk Anti Obesity Drugs Main Business and Markets Served
Table Eisai Anti Obesity Drugs Production Sites and Area Served
Table Eisai Anti Obesity Drugs Product Introduction, Application and Specification
Table Eisai Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Eisai Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Eisai Anti Obesity Drugs Production Market Share (2014-2019)
Figure Eisai Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Eisai Anti Obesity Drugs Main Business and Markets Served
Table Norgine Anti Obesity Drugs Production Sites and Area Served
Table Norgine Anti Obesity Drugs Product Introduction, Application and Specification
Table Norgine Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Norgine Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Norgine Anti Obesity Drugs Production Market Share (2014-2019)
Figure Norgine Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Norgine Anti Obesity Drugs Main Business and Markets Served
Table Arena Pharmaceuticals Anti Obesity Drugs Production Sites and Area Served
Table Arena Pharmaceuticals Anti Obesity Drugs Product Introduction, Application and Specification
Table Arena Pharmaceuticals Anti Obesity Drugs Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Arena Pharmaceuticals Anti Obesity Drugs Production Growth Rate (2014-2019)
Table Arena Pharmaceuticals Anti Obesity Drugs Production Market Share (2014-2019)
Figure Arena Pharmaceuticals Anti Obesity Drugs Revenue Market Share (2014-2019)
Table Arena Pharmaceuticals Anti Obesity Drugs Main Business and Markets Served
Table Orexigen Therapeutics Anti Obesity Drugs Production Sites and Area Served
Table Vivus Anti Obesity Drugs Production Sites and Area Served
Table Alizyme Anti Obesity Drugs Production Sites and Area Served
Table Rhythm Pharmaceuticals Anti Obesity Drugs Production Sites and Area Served
Table Shionogi Anti Obesity Drugs Production Sites and Area Served
Table Zafgan Anti Obesity Drugs Production Sites and Area Served
Figure Global Anti Obesity Drugs Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Anti Obesity Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Anti Obesity Drugs Sales Price (USD/MT) Forecast 2019-2025
Figure North America Anti Obesity Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Anti Obesity Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Anti Obesity Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Anti Obesity Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Anti Obesity Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Anti Obesity Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Anti Obesity Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Anti Obesity Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Anti Obesity Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Anti Obesity Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Anti Obesity Drugs Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Anti Obesity Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Anti Obesity Drugs by Type (2019-2025)
Table Global Consumption (K MT) of Anti Obesity Drugs by Application (2019-2025)
Table Anti Obesity Drugs Distributors List
Table Anti Obesity Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Companies
Pfizer
Merck
Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan
- PRICE
-
$3500$7000$5250Buy Now